Pangaea Oncology, S.A. (PANG.MC)

EUR 1.68

(0.0%)

Total Liabilities Summary of Pangaea Oncology, S.A.

Pangaea Oncology, S.A.'s latest annual total liabilities in 2023 was 10.02 Million EUR , up 89.1% from previous year.
Pangaea Oncology, S.A.'s latest quarterly total liabilities in 2023 FY was 10.02 Million EUR , up 89.1% from previous quarter.
Pangaea Oncology, S.A. reported annual total liabilities of 5.3 Million EUR in 2022, down -21.63% from previous year.
Pangaea Oncology, S.A. reported annual total liabilities of 6.76 Million EUR in 2021, down -21.4% from previous year.
Pangaea Oncology, S.A. reported quarterly total liabilities of 5.6 Million EUR for 2023 Q1, up 5.79% from previous quarter.
Pangaea Oncology, S.A. reported quarterly total liabilities of 5.6 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Total Liabilities of Pangaea Oncology, S.A. (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	10.02 Million EUR	89.1%
2022	5.3 Million EUR	-21.63%
2021	6.76 Million EUR	-21.4%
2020	8.6 Million EUR	0.5%
2019	8.56 Million EUR	-27.04%
2018	11.73 Million EUR	-15.61%
2017	13.9 Million EUR	16.96%
2016	11.89 Million EUR	19.45%
2015	9.95 Million EUR	45.67%
2014	6.83 Million EUR	45.04%
2013	4.71 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 FY	10.02 Million EUR	89.1%
2023 Q1	5.6 Million EUR	5.79%
2023 Q2	5.6 Million EUR	0.0%
2023 Q4	10.02 Million EUR	0.0%
2023 Q3	10.02 Million EUR	78.75%
2022 Q4	5.3 Million EUR	0.0%
2022 FY	5.3 Million EUR	-21.63%
2022 Q2	7.24 Million EUR	0.0%
2021 FY	6.76 Million EUR	-21.4%
2021 Q4	6.76 Million EUR	0.0%
2021 Q2	7.89 Million EUR	0.0%
2020 Q2	10.42 Million EUR	0.0%
2020 FY	8.6 Million EUR	0.5%
2020 Q4	8.6 Million EUR	0.0%
2019 Q4	8.56 Million EUR	0.0%
2019 FY	8.56 Million EUR	-27.04%
2019 Q2	8.45 Million EUR	0.0%
2018 Q4	11.73 Million EUR	0.0%
2018 Q2	12.4 Million EUR	0.0%
2018 FY	11.73 Million EUR	-15.61%
2017 FY	13.9 Million EUR	16.96%
2017 Q4	13.9 Million EUR	0.0%
2017 Q2	11.95 Million EUR	0.0%
2016 Q2	12 Million EUR	0.0%
2016 FY	11.89 Million EUR	19.45%
2016 Q4	11.89 Million EUR	0.0%
2015 Q4	9.95 Million EUR	0.0%
2015 FY	9.95 Million EUR	45.67%
2014 FY	6.83 Million EUR	45.04%
2013 FY	4.71 Million EUR	0.0%

Peer Total Liabilities Comparison of Pangaea Oncology, S.A.

Name	Total Liabilities	Total Liabilities Difference
Clínica Baviera, S.A.	86.36 Million EUR	88.392%